Back to User profile » Dr Alida Benfante

Papers published by Dr Alida Benfante:


Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta Jnr D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N

Journal of Asthma and Allergy 2021, 14:163-173

Published Date: 22 February 2021

The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

Benfante A, Basile M, Battaglia S, Spatafora M, Scichilone N

Therapeutics and Clinical Risk Management 2016, 12:1553-1562

Published Date: 14 October 2016

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

Scichilone N, Battaglia S, Benfante A, Bellia V

Clinical Interventions in Aging 2013, 8:1329-1337

Published Date: 2 October 2013

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations [Corrigendum]

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:67-68

Published Date: 24 May 2013

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:41-42

Published Date: 20 March 2013

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:11-21

Published Date: 9 January 2013